X-640851-C-T
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_000451.4(SHOX):c.517C>T(p.Arg173Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,461,668 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R173H) has been classified as Pathogenic.
Frequency
Consequence
NM_000451.4 missense
Scores
Clinical Significance
Conservation
Publications
- Leri-Weill dyschondrosteosisInheritance: XL, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
- Langer mesomelic dysplasiaInheritance: Unknown, XL, AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Orphanet, Labcorp Genetics (formerly Invitae)
- SHOX-related short statureInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SHOX | NM_000451.4 | c.517C>T | p.Arg173Cys | missense_variant | Exon 3 of 5 | ENST00000686671.1 | NP_000442.1 | |
| SHOX | NM_006883.2 | c.517C>T | p.Arg173Cys | missense_variant | Exon 4 of 6 | NP_006874.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SHOX | ENST00000686671.1 | c.517C>T | p.Arg173Cys | missense_variant | Exon 3 of 5 | NM_000451.4 | ENSP00000508521.1 | |||
| SHOX | ENST00000381575.6 | c.517C>T | p.Arg173Cys | missense_variant | Exon 3 of 5 | 1 | ENSP00000370987.1 | |||
| SHOX | ENST00000381578.6 | c.517C>T | p.Arg173Cys | missense_variant | Exon 4 of 6 | 5 | ENSP00000370990.1 | |||
| SHOX | ENST00000334060.8 | c.517C>T | p.Arg173Cys | missense_variant | Exon 4 of 6 | 5 | ENSP00000335505.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461668Hom.: 0 Cov.: 33 AF XY: 0.00000138 AC XY: 1AN XY: 727146 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Leri-Weill dyschondrosteosis Pathogenic:3
- -
Our laboratory reported dual molecular diagnoses in ALG6 (NM_013339.3:c.257+5G>A; NM_013339.3:c.988G>T; in trans) and SHOX (NM_000451.3:c.517C>T) in an individual with mild hypotonia, poor feeding, congenital heart disease (VSD, PFO, PDA), seizure disorder, dysmorphic facies, small chest wall, bowed lower legs, apparently short upper extremities, shallow sacral dimple, small for gestational age and a history of prematurity and intrauterine growth restriction. -
Variant summary: SHOX c.517C>T (p.Arg173Cys) results in a non-conservative amino acid change located in the Homeobox domain (IPR001356) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251182 control chromosomes. c.517C>T has been reported in the literature in a consanguineous family demonstrating a pseudodominant inheritance pattern with multiple individuals affected with Langer Mesomelic Dysplasia (homozygous genotype) or Leri-Weill Dyschondrosteosis (hemizygous or heterozygous genotype) and as a de-novo variant in settings of exome sequencing performed in infants with a dual molecular diagnosis of Leri-Weill Dyschondrosteosis and autosomal recessive Congenital disorder of glycosylation, type Ic (example, Meng_2017). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function reporting impaired nuclear localization, impaired DNA binding ability and roughly 50% decrease in homodimerization ability (Schneider_2005). Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
not provided Pathogenic:3
Published functional studies demonstrate a damaging effect (reduced dimerization ability) (PMID: 15931687); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 19309509, 27959697, 24421874, 20148114, 11403039, 21262861, 12116253, 15173321, 28973083, 36307859, 15931687) -
The SHOX c.517C>T; p.Arg173Cys variant (rs137852556, ClinVar Variation ID: 9878) is reported in the literature in a consanguineous family in heterozygous individuals with Leri-Weill dyschondrosteosis and homozygous individuals with Langer mesomelic dysplasia (Shears 2002) and was found to segregate with disease in a second family with dyschondrosteosis (Huber 2001). In addition, this variant is reported in exome studies in individuals who have a SHOX-related phenotype (Fu 2022, Meng 2017). This variant is absent from the Genome Aggregation Database (v2.1.1), indicating it is not a common polymorphism. Functional analyses of the variant protein show this variant impairs nuclear localization and DNA binding ability (Sabherwal 2004, Schneider 2005). Computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.692). Based on available information, this variant is considered to be pathogenic. References: Fu F et al. Application of exome sequencing for prenatal diagnosis of fetal structural anomalies: clinical experience and lessons learned from a cohort of 1618 fetuses. Genome Med. 2022 Oct 28;14(1):123. PMID: 36307859. Huber C et al. SHOX point mutations in dyschondrosteosis. J Med Genet. 2001 May;38(5):323. PMID: 11403039. Meng L et al. Use of Exome Sequencing for Infants in Intensive Care Units: Ascertainment of Severe Single-Gene Disorders and Effect on Medical Management. JAMA Pediatr. 2017 Dec 4;171(12):e173438. PMID: 28973083. Sabherwal N et al. Impairment of SHOX nuclear localization as a cause for Léri-Weill syndrome. J Cell Sci. 2004 Jun 15;117(Pt 14):3041-8. PMID: 15173321. Schneider KU et al. Alteration of DNA binding, dimerization, and nuclear translocation of SHOX homeodomain mutations identified in idiopathic short stature and Leri-Weill dyschondrosteosis. Hum Mutat. 2005 Jul;26(1):44-52. PMID: 15931687. Shears DJ et al. Pseudodominant inheritance of Langer mesomelic dysplasia caused by a SHOX homeobox missense mutation. Am J Med Genet. 2002 Jun 15;110(2):153-7. PMID: 12116253. -
- -
SHOX-related disorder Pathogenic:1
The SHOX c.517C>T variant is predicted to result in the amino acid substitution p.Arg173Cys. This variant in the heterozygous condition was reported to be pathogenic for Leri-Weill Dyschondrosteosis (see Family 8, Huber et al. 2001. PubMed ID: 11403039). In the compound heterozygous condition, this variant was reported to be pathogenic for Langer mesomelic dysplasia (Kant et al. 2011. PubMed ID: 21068148). This variant was also reported as a de novo variant in one patient with dual diagnosis who also had two compound heterozygous ALG6 variants (see eTable 4, Meng et al. 2017. PubMed ID: 28973083). Functional studies suggest that the p.Arg173Cys variant led to disrupted protein nuclear localization (Sabherwal et al. 2004. PubMed ID: 15173321). In summary, we consider this variant pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at